Doceere Series B funding from Creageis

Investec advised Doceree on its USD 35 million fundraise from Creageis

Investec India acted as the Exclusive financial Advisor to Doceere during their Series B fundraise. Doceere raised $35mn in equity capital from a consortium of investors led by Creageis Advisors with participation from Existing Investors Eight Roads Ventures and F-Prime Capital.

Investec's role:

As lead advisor, Investec leveraged our global presence and healthcare technology expertise in leading Doceree’s pivotal funding round. We tapped into our extensive cross-border investor network spanning USA, Europe, and India to connect with over 50 potential investors.
Investec utilized its deep understanding of Doceree’s business model and the healthcare advertising sector, thereby positioning the company as the singular player to control the entire supply chain through tight integrations across demand and supply-side platforms, thereby controlling customer experience.
Investec ensured seamless coordination between diligence and legal advisors across the globe, thereby ensuring all parties stick to the transaction timeline and achieving an outcome the company envisioned.

About Doceree:

Doceree is a healthcare marketing company that provides programmatic messaging solutions to pharmaceutical and life-sciences companies and healthcare media agencies. The company's focus is on Health Care Professionals (HCPs), and it offers a global network of HCP-only digital platforms to drive better patient health outcomes. Doceree's innovative AI-enabled technology simplifies HCP engagement globally, providing end-to-end HCP-targeting solutions. The company's disruptive products have garnered significant adoption of programmatic technology, with 69% of pharma marketers in the US favoring programmatic messaging platforms for improved HCP reach.

Client feedback:

“We are pioneering HCP messaging solutions that are first to market. It is incredible to watch our innovative products disrupt the space and drive adoption of programmatic technology in the life-sciences industry, not just in evolved markets like the US, but also elsewhere in the same vein. We have been able to simplify HCP engagement globally with our unique AI-enabled proprietary technology and offer quality end-to-end HCP-targeting solutions that have helped our clients succeed with profitable growth. The pharma messaging space is evolving at a fast pace and our solutions are aligned to meet the immediate requirements of the life sciences industry. The investment speaks volumes about the value we are creating in the space.”
– Harshit Jain, MD, Founder and Global CEO, Doceree